Key facts
- STATE STREET CORP filed SCHEDULE 13G for IOVANCE BIOTHERAPEUTICS INC COMMON STOCK (IOVA).
- Disclosed ownership: 5.1%.
- Date of event: 31 Dec 2025.
STATE STREET CORP - 31 Dec 2025 SCHEDULE 13G Report for IOVANCE BIOTHERAPEUTICS INC COMMON STOCK (IOVA)
- Filing Manager
- STATE STREET CORP
- Reporting Manager
- STATE STREET CORPORATION
- Symbol
- IOVA
- Shares outstanding
- 395,322,451 shares
- Disclosed Ownership
- 20,161,445 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 09 Feb 2026, 06:43:17 UTC
- Date of event
- 31 Dec 2025
- Next filing
- 12 May 2026
- SEC
- View on sec.gov
Key filing fact
STATE STREET CORP disclosed 5.1% ownership in IOVANCE BIOTHERAPEUTICS INC COMMON STOCK (IOVA) on 31 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 Feb 2026, 06:43.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | 5.1% | 20,161,445 | 0 | 19,204,365 | ELIZABETH SCHAEFER | SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER |
CIK / CUSIP context first